Vascular Specialist Online

Vascular Specialist serves as the official publication for the Society for Vascular Surgery.® This bimonthly newspaper is a trusted source for over 4,000 professionals, including vascular surgeons, interventional cardiologists, and vascular and interventional radiologists. They turn to Vascular Specialist for the latest medical news, coverage of medical conferences, and insights from experts, available in both print and digital formats.

International

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#2695151

United States

#734143

Health/Medicine

#4540

Traffic sources

Monthly visitors

Articles

Two-year data show continued clinical improvement with VenoValve

1 day ago | vascularspecialistonline.com | Jocelyn Hudson

Implantation Oof the VenoValve (enVVeno Medical) continues to promote stabilization of symptoms in patients with deep venous reflux at two-year follow-up. This is the headline finding of data shared yesterday during Plenary Session 6 at VAM 2025.
The people and devices that put ‘the vascular in vascular’

1 day ago | vascularspecialistonline.com | Bryan Kay

The people, discoveries, innovations and events that brought the vascular surgery profession to where it is today will form the subject matter for this year’s John Homans Lecture—“Who put the vascular in vascular surgery?”—at VAM 2025. Jerry Goldstone, MD, an adjunct professor at Stanford University College of Medicine, will pore over some of the most important developments in the field since the founding of the SVS in 1946, which set the stage for the modern vascular surgical specialty.
International Chapter highlights pressing need to document PAD and CLTI prevalence in South Asia

2 days ago | vascularspecialistonline.com | Bryan Kay

There is an urgent need for epidemiological studies to map out the prevalence of chronic limb-threatening ischemia (CLTI)—and peripheral arterial disease (PAD) in general—in South Asia, attendees of the International Chapter Education Session at VAM 2025 heard yesterday morning.
Transatlantic multicenter experience highlights effectiveness of total endovascular aortic repair with F/BEVAR but 5% risk of major stroke

2 days ago | vascularspecialistonline.com | Jocelyn Hudson

Staged total endovascular aortic repair (TEAR) utilizing arch branched and thoracoabdominal fenestrated and branched endografts is effective, but identified predictors of morbidity and mortality—including stroke—highlight the importance of individualized risk assessment to optimize outcomes. These are some of the key findings of a study presented during yesterday’s Plenary Session 3.
Impact report finds no major change in balance between CAS and CEA following Medicare expansion

3 days ago | vascularspecialistonline.com | Eva Malpass

An evaluation of trends in the utilization of carotid artery stenting (CAS) versus carotid endarterectomy (CEA) has found there to be “no major change” to tip the balance following the 2023 US Centers for Medicare and Medicaid Services (CMS) expansion of CAS coverage to include standard-risk patients with symptomatic ≥50% and asymptomatic ≥70% carotid artery stenosis. Courtenay M.
Transcatheter arterialization of the deep veins: Comparative analysis probes whether emerging modality is worth pursuing

3 days ago | vascularspecialistonline.com | Bryan Kay

“We’re living in a new world order” when it comes to “no-option” chronic limb-threatening ischemia (CLTI) patients, says Anahita Dua, MD. In recent years, into this arena has stepped transcatheter arterialization of the deep veins (TADV), raising hopes of reducing amputation rates amid a rise in diabetes and other disease affecting microvascular dissemination.
Drilling into controversies in field of asymptomatic severe carotid stenosis management

3 days ago | vascularspecialistonline.com | Bryan Kay

Some of the enduring controversies in the management of asymptomatic severe carotid stenosis will underpin an educational session set to take place today. The session tackles debate around the deployment of carotid revascularization strategies in both standard- and high-risk patient populations.
Speaking in code: How a decline in Medicare reimbursement affects vascular care

3 days ago | vascularspecialistonline.com | Eva Malpass

Concerns were raised yesterday’s Plenary Session 2 over the recent decline in Medicare reimbursement at a national level. Querying current figures, speakers revealed discrepancies which highlight the importance of accurate reporting to ensure sustainable provision for the future of vascular care. Opening the session, Kirthi S.
One-year TAMBE data highlight low mortality, importance of renal branch assessment

3 days ago | vascularspecialistonline.com | Jocelyn Hudson

The four-branch Gore Excluder thoracoabdominal branch endoprosthesis (TAMBE) device demonstrated low mortality at one year with renal artery occlusion being the predominant device-related event associated with small renal arteries and pararenal aneurysms. So concluded Mark A. Farber, MD, presenting the latest TAMBE data during yesterday’s William J. von Liebig Forum.
No power, no problem! VAM 2025 pivots as early-morning power outage delays meeting opening

3 days ago | vascularspecialistonline.com | Bryan Kay

The vascular surgery world is used to pivoting on a dime. So it was as VAM 2025 was about to commence yesterday morning, and power outage problems led to a delayed start to this year’s SVS annual meeting. “We talk in vascular surgery about having to have multiple plans as we go into the operating room,” quipped SVS President Matthew Eagleton, MD, as attendees corralled into an alternative meeting room due to the technical difficulties besetting the main plenary hall.